These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 11737696

  • 1. Treatment of anogenital warts in children with topical 0.05% podofilox gel and 5% imiquimod cream.
    Moresi JM, Herbert CR, Cohen BA.
    Pediatr Dermatol; 2001; 18(5):448-50; discussion 452. PubMed ID: 11737696
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of imiquimod versus podophyllotoxin in the treatment of anogenital warts.
    Komericki P, Akkilic-Materna M, Strimitzer T, Aberer W.
    Sex Transm Dis; 2011 Mar; 38(3):216-8. PubMed ID: 20938374
    [Abstract] [Full Text] [Related]

  • 3. Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.
    Gilson R, Nugent D, Bennett K, Doré CJ, Murray ML, Meadows J, Haddow LJ, Lacey C, Sandmann F, Jit M, Soldan K, Tetlow M, Caverly E, Nathan M, Copas AJ.
    Health Technol Assess; 2020 Sep; 24(47):1-86. PubMed ID: 32975189
    [Abstract] [Full Text] [Related]

  • 4. [A model-based comparison of cost effectiveness of imiquimod versus podophyllotoxin for the treatment of external anogenital warts in France].
    Lafuma A, Monsonego J, Moyal-Barracco M, Pribil C.
    Ann Dermatol Venereol; 2003 Sep; 130(8-9 Pt 1):731-6. PubMed ID: 14576602
    [Abstract] [Full Text] [Related]

  • 5. Self-administered topical 5% imiquimod cream for external anogenital warts. HPV Study Group. Human PapillomaVirus.
    Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, Hougham AJ, Schmitt KA.
    Arch Dermatol; 1998 Jan; 134(1):25-30. PubMed ID: 9449906
    [Abstract] [Full Text] [Related]

  • 6. Imiquimod: a review.
    Gupta AK, Browne M, Bluhm R.
    J Cutan Med Surg; 2002 Jan; 6(6):554-60. PubMed ID: 12362256
    [Abstract] [Full Text] [Related]

  • 7. Treatment of anogenital warts with imiquimod 5% cream followed by surgical excision of residual lesions.
    Carrasco D, vander Straten M, Tyring SK.
    J Am Acad Dermatol; 2002 Oct; 47(4 Suppl):S212-6. PubMed ID: 12271280
    [Abstract] [Full Text] [Related]

  • 8. Treatment of human papillomavirus in childhood with imiquimod 5% cream.
    Brandt HR, Fernandes JD, Patriota RC, Criado PR, Belda Junior W.
    An Bras Dermatol; 2010 Oct; 85(4):549-53. PubMed ID: 20944919
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of perianal warts in a child with 5% imiquimod cream.
    Gruber PC, Wilkinson J.
    J Dermatolog Treat; 2001 Dec; 12(4):215-7. PubMed ID: 12241631
    [Abstract] [Full Text] [Related]

  • 10. Topical imiquimod: a review of its use in genital warts.
    Perry CM, Lamb HM.
    Drugs; 1999 Aug; 58(2):375-90. PubMed ID: 10473026
    [Abstract] [Full Text] [Related]

  • 11. Effectiveness of imiquimod 5% cream for treatment of extensive anogenital warts in a seven-year-old child.
    Campaner AB, Santos RE, Galvão MA, Beznos GW, Aoki T.
    Pediatr Infect Dis J; 2007 Mar; 26(3):265-6. PubMed ID: 17484228
    [Abstract] [Full Text] [Related]

  • 12. A short, 8-week course of imiquimod 5% cream versus podophyllotoxin in the treatment of anogenital warts: A retrospective comparative cohort study.
    Nicolaidou E, Kanelleas A, Nikolakopoulos S, Bezrodnii G, Nearchou E, Gerodimou M, Papadopoulou-Skordou E, Paparizos V, Rigopoulos D.
    Indian J Dermatol Venereol Leprol; 2021 Mar; 87(5):666-670. PubMed ID: 31650979
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts.
    Tyring S, Edwards L, Cherry LK, Ramsdell WM, Kotner S, Greenberg MD, Vance JC, Barnum G, Dromgoole SH, Killey FP, Toter T.
    Arch Dermatol; 1998 Jan; 134(1):33-8. PubMed ID: 9449907
    [Abstract] [Full Text] [Related]

  • 15. Extensive condyloma acuminata treated with imiquimod 5% cream: a case report.
    Cox JT.
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():51-4. PubMed ID: 14616817
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Topical imiquimod.
    Pearson GW, Langley RG.
    J Dermatolog Treat; 2001 Mar; 12(1):37-40. PubMed ID: 12171687
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Imiquimod 5% cream for external genital or perianal warts in human immunodeficiency virus-positive patients treated with highly active antiretroviral therapy: an open-label, noncomparative study.
    Saiag P, Bauhofer A, Bouscarat F, Aquilina C, Ortonne JP, Dupin N, Mougin C.
    Br J Dermatol; 2009 Oct; 161(4):904-9. PubMed ID: 19466962
    [Abstract] [Full Text] [Related]

  • 20. Imiquimod in clinical practice.
    Edwards L.
    Australas J Dermatol; 1998 Nov; 39 Suppl 1():S14-6. PubMed ID: 9842096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.